Bionical Solutions

Bionical provides high quality clinical, commercial and communications services to pharmaceutical, biotech and public health companies in the global healthcare industry. With a mission to improve health outcomes, Bionical's services accelerate product and treatment development and enhance communication and engagement with healthcare professionals and patients. Bionical's services span the product lifecycle and include comparator supply for clinical trials, clinical educator services, contract sales solutions, recruitment, digital and educational platforms. In addition, in the UK Bionical provides industry leading public health services such as Quit 51, a stop smoking service that uses the latest research, evidence and licensed medication to support patients to stop smoking. Our team work with leading academics publishing outcomes and ensuring we are delivering cutting edge services that lead the field.

Andrew Borkowski

Executive Chairman

1 past transactions

Emas Pharma

Acquisition in 2016
Emas Pharma provides pharmaceutical and device development services worldwide and specializes in partnering with specialist pharma and biotech companies. Emas has in-depth expertise in complex small early phase and large global pivotal studies and all the regulatory and drug safety implications. Emas works as part of the client team and its expert team will stay on your project. Emas continues to partner right the way through the product lifecycle by providing medical affairs and medical information support, clinical services for post-marketing commitments and continued pharmacovigilance capability. Emas Pharma provides services globally through its offices in USA, Canada, Ireland, Australia and the UK and can deliver high quality full-service drug development solutions whilst retaining flexibility and delivering value.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.